Literature DB >> 27476666

CETP Activity: A Link between Lipid Metabolism and Coagulation System.

Kinta Hatakeyama1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27476666      PMCID： PMC5098913          DOI： 10.5551/jat.ED053

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  9 in total

Review 1.  Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism: why have they failed in lowering coronary heart disease risk?

Authors:  Ernst J Schaefer
Journal:  Curr Opin Lipidol       Date:  2013-06       Impact factor: 4.776

2.  Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.

Authors:  S Riemens; A van Tol; W Sluiter; R Dullaart
Journal:  Atherosclerosis       Date:  1998-09       Impact factor: 5.162

3.  Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome.

Authors:  S Braschi; D Masson; G Rostoker; E Florentin; A Athias; C Martin; B Jacotot; P Gambert; C Lallemant; L Lagrost
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-11       Impact factor: 8.311

Review 4.  Epidemiology and risk factors for venous thrombosis.

Authors:  Mary Cushman
Journal:  Semin Hematol       Date:  2007-04       Impact factor: 3.851

Review 5.  Tissue Factor and Atherothrombosis.

Authors:  Kohei Tatsumi; Nigel Mackman
Journal:  J Atheroscler Thromb       Date:  2015-05-27       Impact factor: 4.928

6.  Relationship between cholesteryl ester transfer protein and atherogenic lipoprotein profile in morbidly obese women.

Authors:  C F Ebenbichler; M Laimer; S Kaser; A Ritsch; A Sandhofer; H Weiss; F Aigner; J R Patsch
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-09-01       Impact factor: 8.311

Review 7.  Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese.

Authors:  Makoto Nagano; Shizuya Yamashita; Ken-Ichi Hirano; Mayumi Takano; Takao Maruyama; Mitsuaki Ishihara; Yukiko Sagehashi; Takeshi Kujiraoka; Kazuya Tanaka; Hiroaki Hattori; Naohiko Sakai; Norimichi Nakajima; Tohru Egashira; Yuji Matsuzawa
Journal:  J Atheroscler Thromb       Date:  2004       Impact factor: 4.928

8.  Neutral lipid transfer activities in the plasma of patients with abetalipoproteinemia.

Authors:  A S Pappu; D R Illingworth
Journal:  Atherosclerosis       Date:  1988-05       Impact factor: 5.162

9.  Elevated CETP Lipid Transfer Activity is Associated with the Risk of Venous Thromboembolism.

Authors:  Hiroshi Deguchi; Yajnavalka Banerjee; Darlene J Elias; John H Griffin
Journal:  J Atheroscler Thromb       Date:  2016-05-09       Impact factor: 4.928
  9 in total
  2 in total

Review 1.  Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan.

Authors:  Mashio Nakamura; Norikazu Yamada; Masaaki Ito
Journal:  J Atheroscler Thromb       Date:  2017-04-07       Impact factor: 4.928

2.  Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.

Authors:  Peter Nash; Andreas Kerschbaumer; Thomas Dörner; Maxime Dougados; Roy M Fleischmann; Klaus Geissler; Iain McInnes; Janet E Pope; Désirée van der Heijde; Michaela Stoffer-Marx; Tsutomu Takeuchi; Michael Trauner; Kevin L Winthrop; Maarten de Wit; Daniel Aletaha; Xenofon Baraliakos; Wolf-Henning Boehncke; Paul Emery; John D Isaacs; Joel Kremer; Eun Bong Lee; Walter P Maksymowych; Marieke Voshaar; Lai-Shan Tam; Yoshiya Tanaka; Filip van den Bosch; René Westhovens; Ricardo Xavier; Josef S Smolen
Journal:  Ann Rheum Dis       Date:  2020-11-06       Impact factor: 19.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.